SPANX-E, a protein associated with specialized cellular functions, is influenced by several biochemical activators that modulate its activity through distinct pathways. For instance, certain compounds that directly activate adenylate cyclase result in elevated levels of cyclic AMP (cAMP), a critical secondary messenger that enhances the expression and activity of SPANX-E. Furthermore, agonists targeting specific adrenergic receptors also elevate cAMP, which suggests a reinforcement of SPANX-E's functional state. The inhibition of phosphodiesterases, enzymes responsible for cAMP degradation, leads to sustained signaling through cAMP-dependent pathways, ultimately benefiting SPANX-E's activation. Additionally, activators of protein kinase C (PKC) may trigger phosphorylation events, which are known to play a pivotal role in the functional enhancement of this protein.
Other molecular entities exert their influence by altering intracellular ion concentrations, such as those that increase calcium levels, thus engaging signaling cascades that could culminate in the activation of SPANX-E. Inhibition of glycogen synthase kinase-3 beta (GSK-3β) by certain small molecules may also instigate a chain of events favorable to SPANX-E activation. The physiological impact of antioxidants is also notable, potentially affecting SPANX-E through their modulation of cellular redox states. Analogously, agents that raise intracellular levels of cyclic GMP (cGMP) indicate a possible indirect upregulation of SPANX-E activity. Furthermore, the role of histamine receptor signaling and chromatin remodeling agents implies a more genomic approach to enhancing SPANX-E's functional repertoire. Finally, the activation of nuclear receptors by specific fatty acids could lead to transcriptional events that elevate the activity of SPANX-E.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Direct activator of adenylate cyclase, leading to increased cAMP levels which can enhance SPANX-E expression and activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
β-adrenergic receptor agonist that increases cAMP levels, thereby potentially enhancing the activity of SPANX-E. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Phosphodiesterase inhibitor that prevents cAMP degradation, potentially increasing SPANX-E activity through elevated cAMP. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Direct activator of protein kinase C (PKC), which may lead to phosphorylation and activation of SPANX-E. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Calcium ionophore that raises intracellular calcium levels, potentially inducing signaling pathways that activate SPANX-E. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, possibly leading to activation of signaling pathways that enhance SPANX-E activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Antioxidant that could influence signaling pathways through its effect on oxidative stress, potentially activating SPANX-E. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
cAMP analog that activates cAMP-dependent pathways, which could lead to the activation of SPANX-E. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $92.00 $277.00 $969.00 | 7 | |
Activates G protein-coupled histamine receptors, potentially influencing signaling pathways that activate SPANX-E. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Histone deacetylase inhibitor that can lead to chromatin remodeling, potentially enhancing SPANX-E activity. |